Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DE Group
AddedFeb 17, 2024
UpdatedJun 18, 2026
DE Group

DE Group

Series D

DE Group: Comprehensive pharmaceutical wholesaler offering generics, imports, OTCs, and more.

HQ
Yorkshire, NY, US
Founded
1995
Overview
Compare
Fundraising
Employees

DE Group is a comprehensive pharmaceutical wholesaler dedicated to providing a full range of products, including generics, parallel imports, ethicals, dressings, feeds, OTCs, dispensary consumables, veterinary products, and specials. The company's mission is to ensure a reliable supply of high-quality pharmaceuticals to healthcare providers and pharmacies.

DE Group has established itself as a key player in the pharmaceutical distribution market, known for its extensive product range and commitment to quality. The company has built strong relationships with healthcare providers, ensuring efficient and timely delivery of essential medical supplies.

DE Group - Similar Companies

Phoenix Pharmahandel logo

Phoenix Pharmahandel

phoenixgroup.eu

Dexcel Pharma logo

Dexcel Pharma

dexcel.com

Leading Pharma logo

Leading Pharma

leadingpharma.com

A&G Pharmaceutical logo

A&G Pharmaceutical

Masters Pharmaceutical logo

Masters Pharmaceutical

mastersrx.com

DeuteRx logo

DeuteRx

deuterx.com

Tagent logo

Tagent

GeniusRx logo

GeniusRx

geniusrx.com

Vertice Pharma logo

Vertice Pharma

Kalyra Pharmaceuticals logo

Kalyra Pharmaceuticals

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Dawah Pharmaceuticals logo

Dawah Pharmaceuticals

dawahpharma.com

Apothecary Products logo

Apothecary Products

Bell Net logo

Bell Net

webmail.bell.net

ScripsAmerica logo

ScripsAmerica

DE Group - Quick Facts

Who are DE Group's competitors?

Companies similar to DE Group include Phoenix Pharmahandel, Dexcel Pharma, Leading Pharma and A&G Pharmaceutical.

When was DE Group founded?

DE Group was founded in 1995.

Where is DE Group's headquarters located?

DE Group's headquarters is located in Yorkshire, NY, US.

When was DE Group's last funding round?

DE Group's most recent funding round was for $37M (USD) in October 2013.

How much has DE Group raised to-date?

As of Oct 23, 2013, DE Group has raised a total of $37M (USD).

How many employees does DE Group have?

DE Group has 30 employees as of Feb 4, 2024.

DE Group - Classification

Ownership
  • Private
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Pharmaceuticals
  • Wholesale
Tags
  • Distribution
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 10 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified